Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisy Zamora

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Expert Opinion on Pharmacotherapy|August 18, 2021
Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indicationJohn Davis, Daisy Zamora, Mark Horowitz, et al.
CNS Spectrums|February 20, 2019
Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatmentIra D Glick, Daisy Zamora, Danielle Kamis, et al.
The American Journal of Clinical Nutrition|August 6, 2010
Diet quality and weight gain among black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study (1985-2005)Daisy Zamora, Penny Gordon-Larsen, David R Jacobs, et al.
Journal of Clinical Psychopharmacology|February 15, 2017
Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up StudyIra D Glick, John M Davis, Daisy Zamora, et al.
Journal of Clinical Psychopharmacology|March 7, 2020
Are Patients With Schizophrenia Better Off With Lifetime Antipsychotic Medication?: Replication of a Naturalistic, Long-Term, Follow-Up Study of Antipsychotic TreatmentIra D Glick, Daisy Zamora, John M Davis, et al.
Diabetes Care|April 12, 2011
Are the 2005 Dietary Guidelines for Americans Associated With reduced risk of type 2 diabetes and cardiometabolic risk factors? Twenty-year findings from the CARDIA studyDaisy Zamora, Penny Gordon-Larsen, Ka He, et al.
Journal of Agricultural and Food Chemistry|February 4, 2017
Lipidomic Analysis of Oxidized Fatty Acids in Plant and Algae OilsChristine E Richardson, Marie Hennebelle, Yurika Otoki, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2016
Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acidAmeer Y Taha, Marie Hennebelle, Jun Yang, et al.
The British Journal of Nutrition|January 19, 2013
Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical researchBeth A MacIntosh, Christopher E Ramsden, Keturah R Faurot, et al.
Schizophrenia Research|November 21, 2018
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trialMark Weiser, Linda Levi, Shimon Burshtein, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|August 18, 2021
Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indicationJohn Davis, Daisy Zamora, Mark Horowitz, et al.
CNS Spectrums|February 20, 2019
Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatmentIra D Glick, Daisy Zamora, Danielle Kamis, et al.
The American Journal of Clinical Nutrition|August 6, 2010
Diet quality and weight gain among black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study (1985-2005)Daisy Zamora, Penny Gordon-Larsen, David R Jacobs, et al.
Journal of Clinical Psychopharmacology|February 15, 2017
Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up StudyIra D Glick, John M Davis, Daisy Zamora, et al.
Journal of Clinical Psychopharmacology|March 7, 2020
Are Patients With Schizophrenia Better Off With Lifetime Antipsychotic Medication?: Replication of a Naturalistic, Long-Term, Follow-Up Study of Antipsychotic TreatmentIra D Glick, Daisy Zamora, John M Davis, et al.
Diabetes Care|April 12, 2011
Are the 2005 Dietary Guidelines for Americans Associated With reduced risk of type 2 diabetes and cardiometabolic risk factors? Twenty-year findings from the CARDIA studyDaisy Zamora, Penny Gordon-Larsen, Ka He, et al.
Journal of Agricultural and Food Chemistry|February 4, 2017
Lipidomic Analysis of Oxidized Fatty Acids in Plant and Algae OilsChristine E Richardson, Marie Hennebelle, Yurika Otoki, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2016
Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acidAmeer Y Taha, Marie Hennebelle, Jun Yang, et al.
The British Journal of Nutrition|January 19, 2013
Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical researchBeth A MacIntosh, Christopher E Ramsden, Keturah R Faurot, et al.
Schizophrenia Research|November 21, 2018
The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trialMark Weiser, Linda Levi, Shimon Burshtein, et al.
Pageof 5